Hologic Inc. (HOLX)

38.85
NASDAQ : Health Technology
Prev Close 38.85
Day Low/High 0.00 / 0.00
52 Wk Low/High 35.33 / 46.80
Avg Volume 2.73M
Exchange NASDAQ
Shares Outstanding 276.53M
Market Cap 10.86B
EPS 2.70
P/E Ratio 10.26
Div & Yield N.A. (N.A)

Latest News

Aptima® HBV Quant Assay For Quantitation Of Hepatitis B Viral Load Receives PMA Approval

Aptima® HBV Quant Assay For Quantitation Of Hepatitis B Viral Load Receives PMA Approval

--Aptima assay portfolio rapidly expanding with the addition of tests to quantitate HIV-1, HCV and HBV now available on the fully automated Panther system--

Hologic's Cynosure Division Launches TempSure™ Envi

Hologic's Cynosure Division Launches TempSure™ Envi

--Superior Radiofrequency Treatment Minimizes Fine Facial Lines and Wrinkles, Tightens Skin Through Soft Tissue Coagulation, and Improves the Appearance of Cellulite--

Hologic Announces Offering Of $1 Billion Of Senior Notes

Hologic Announces Offering Of $1 Billion Of Senior Notes

- Proceeds Expected to Contribute to Retirement of All Outstanding 5.25% Senior Notes due 2022 -

Bring On the Bitcoin Futures Trading Insanity!

Bring On the Bitcoin Futures Trading Insanity!

Bitcoin futures trading kicks off on Sunday. You ready? Do you even care? Hey, the worst thing that could happen is that the avalanche of millionaires chasing bitcoin is so great the internet shuts down for hours.

Six Off the Beaten Path Healthcare Stock Gems

Six Off the Beaten Path Healthcare Stock Gems

These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.

Third Respiratory Assay Now FDA Cleared On Hologic's New Panther Fusion® System

Third Respiratory Assay Now FDA Cleared On Hologic's New Panther Fusion® System

-- New Assay Detects Adenovirus, Human Metapneumovirus and Rhinovirus --

Hologic Signs Development And Distribution Agreement With Clarius Mobile Health For Innovative Ultrasound System

Hologic Signs Development And Distribution Agreement With Clarius Mobile Health For Innovative Ultrasound System

Partnership will help Hologic drive global access to critical breast health services

Hologic Receives FDA 510(k) Clearance Of Quantra™ 2.2 Breast Density Assessment Software

Hologic Receives FDA 510(k) Clearance Of Quantra™ 2.2 Breast Density Assessment Software

--Latest addition to market-leading portfolio of innovative breast and skeletal health solutions to be featured at RSNA 2017--

These Stocks Have Changed Direction

These Stocks Have Changed Direction

Finding bullish and bearish reversals in the market.

Hologic Becomes #180 Most Shorted S&P 500 Component, Replacing Kinder Morgan

Hologic Becomes #180 Most Shorted S&P 500 Component, Replacing Kinder Morgan

The most recent short interest data has been released for the 10/31/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

How to Buy Great, Cheap Stocks When Indexes Are at All-Time Highs

How to Buy Great, Cheap Stocks When Indexes Are at All-Time Highs

As the market keeps reaching all-time highs, the mantra of 'buying low, sell high' isn't always that easy. Here's how to strategize.

Paraflu Assay Now FDA Cleared On Hologic's New Panther Fusion® System

Paraflu Assay Now FDA Cleared On Hologic's New Panther Fusion® System

-- New Assay Extends Respiratory Testing Menu; Modular Panels and Fusion System Increase Efficiency and Flexibility for the Laboratory --

Panther Fusion® Flu A/B/RSV Assay Now FDA Cleared On Hologic's New Panther Fusion® System

Panther Fusion® Flu A/B/RSV Assay Now FDA Cleared On Hologic's New Panther Fusion® System

- New Panther Fusion Module Expands System's Molecular Testing Capabilities, Increases Efficiency and Flexibility for the Laboratory

Hologic Announces Offering Of $350 Million Of Senior Notes Due 2025

Hologic Announces Offering Of $350 Million Of Senior Notes Due 2025

- Proceeds Expected to Contribute to Retirement of Remaining Convertible Notes -

Hologic Enters Into Amended And Restated Five-Year Secured Credit Agreement

Hologic Enters Into Amended And Restated Five-Year Secured Credit Agreement

- Initial Proceeds from New $1.5 Billion Term Loan and $1.5 Billion Revolving Credit Line Used to Refinance Senior Secured Debt -

Hologic CEO Steve MacMillan To Ring Nasdaq Opening Bell On October 2 To Kick Off Breast Cancer Awareness Month

Hologic CEO Steve MacMillan To Ring Nasdaq Opening Bell On October 2 To Kick Off Breast Cancer Awareness Month

Trailblazing Company Behind the Genius™ 3D Mammography™ Exam Celebrates Year of Innovations in Breast Health

TheStreet Quant Rating: B- (Buy)